References
- Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193. doi:https://doi.org/10.3322/caac.21395
- Kolinsky K, Shen B-Q, Zhang Y-E, Kohles J, Dugan U, Zioncheck TF, Heimbrook D, Packman K, Higgins B. In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models. Mol Cancer Ther. 2009;8(1):75–82. doi:https://doi.org/10.1158/1535-7163.MCT-08-0596
- Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, Ishitsuka H. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol. 1998;55(7):1091–1097. doi:https://doi.org/10.1016/s0006-2952(97)00682-5
- Twelves C. Xeloda Colorectal Cancer Group. Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials. Eur J Cancer. 2002;38(Suppl 2):15–20. doi:https://doi.org/10.1016/S0959-8049(01)00415-4
- Wilke H. Future treatment options with capecitabine in solid tumours. Eur J Cancer. 2002;38(Suppl 2):21–25. doi:https://doi.org/10.1016/S0959-8049(01)00417-8
- Kapral M, Wawszczyk J, Jesse K, Paul-Samojedny M, Kuśmierz D, Węglarz L. Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway. Molecules. 2017;22(10):1657. doi:https://doi.org/10.3390/molecules22101657
- Liu G, Song Y, Cui L, Wen Z, Lu X. Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target. Int J Clin Exp Pathol. 2015;8(2):1402–1410.
- Dinicola S, Fabrizi G, Masiello MG, Proietti S, Palombo A, Minini M, Harrath AH, Alwasel SH, Ricci G, Catizone A, et al. Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement. Exp Cell Res. 2016;345(1):37–50. doi:https://doi.org/10.1016/j.yexcr.2016.05.007
- Fu M, Song Y, Wen Z, Lu X, Cui L. Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice. Nutrients. 2016;8(5):286. doi:https://doi.org/10.3390/nu8050286
- Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006;55(2):109–125. doi:https://doi.org/10.1207/s15327914nc5502_1
- Vucenik I, Tomazic VJ, Fabian D, Shamsuddin AM. Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study. Cancer Lett. 1992;65(1):9–13. doi:https://doi.org/10.1016/0304-3835(92)90206-B
- Vucenik I. Anticancer properties of inositol hexaphosphate and inositol: An overview. J Nutr Sci Vitaminol. 2019;65(Supplement):S18–S22. doi:https://doi.org/10.3177/jnsv.65.S18
- Vucenik I, Yang GY, Shamsuddin AM. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis. 1995;16(5):1055–1058. doi:https://doi.org/10.1093/carcin/16.5.1055
- Khurana S, Baldeo C, Joseph RW. Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report. Melanoma Res. 2019;29(3):322–324. doi:https://doi.org/10.1097/CMR.0000000000000577
- Družijanić N, Juricic J, Perko Z, Kraljevic D. IP6 + Inositol as adjuvant to chemotherapy of colon cancer: our clinical experience. Anticancer Res. 2004;24:3474.
- Bacić I, Druzijanić N, Karlo R, Skifić I, Jagić S. Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study. J Exp Clin Cancer Res. 2010;29(1):12. doi:https://doi.org/10.1186/1756-9966-29-12
- Proietti S, Pasta V, Cucina A, Aragona C, Palombi E, Vucenik I, Bizzarri M. Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):43–50.
- Miller SA, Policastro RA, Savant SS, Sriramkumar S, Ding N, Lu X, Mohammad HP, Cao S, Kalin JH, Cole PA, et al. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA-Mutant Colorectal Cancer. Mol Cancer Res. 2020;18(2):264–277. doi:https://doi.org/10.1158/1541-7786.MCR-19-0748
- Oh BY, Hong HK, Lee WY, Cho YB. Animal models of colorectal cancer with liver metastasis. Cancer Lett. 2017;387:114–120. doi:https://doi.org/10.1016/j.canlet.2016.01.048
- Liu X, Liu C, Chen C, Sun W, Ci Y, Li Q, Song Y. Combination of inositol hexaphosphate and inositol inhibits liver metastasis of colorectal cancer in mice through the Wnt/β-catenin pathway. OTT. 2020;Volume 13:3223–35. doi:https://doi.org/10.2147/OTT.S247646
- Langley RR, Fidler IJ. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs . Int J Cancer. 2011;128((11):2527–2535. doi:https://doi.org/10.1002/ijc.26031
- Pretzsch E, Bösch F, Neumann J, Ganschow P, Bazhin A, Guba M, Werner J, Angele M. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol. 2019;2019:7407190. doi:https://doi.org/10.1155/2019/7407190
- Liu S, Shi L, Wang Y, Ye D, Ju H, Ma H, Yang W, Wang Y, Hu J, Deng J, et al. Stabilization of slug by NF-κB is essential for TNF-α -induced migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma cells. Cell Physiol Biochem. 2018;47(2):567–578. doi:https://doi.org/10.1159/000489990
- Shen Z, Zhou R, Liu C, Wang Y, Zhan W, Shao Z, Liu J, Zhang F, Xu L, Zhou X, et al. MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression. Cell Death Dis. 2017;8(12):3213. doi:https://doi.org/10.1038/s41419-017-0048-x
- Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis [published correction appears. J Clin Invest. 2014;124(4):1853–1867. doi:https://doi.org/10.1172/JCI73531
- Cheng X-S, Li Y-F, Tan J, Sun B, Xiao Y-C, Fang X-B, Zhang X-F, Li Q, Dong J-H, Li M, et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cancer Lett. 2014;348(1-2):77–87. doi:https://doi.org/10.1016/j.canlet.2014.03.008